Galectin Therapeutics reported 1000 in Interest Income for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Galectin Therapeutics GALT:US 1000 1000
Idera Pharmaceuticals IDRA:US 42K 39K
Regulus Therapeutics RGLS:US 6K 35K
Vital Therapies VTL:US 106K 99K